The cost of breast cancer screening for older women has soared because of increased use of new technologies, but that hasn’t led to earlier detection of breast cancer, a new study shows.
Researchers compared data from 2001-02 and 2008-09, and found that the use of screening mammography for Medicare-enrolled women without a history of breast cancer remained at about 42 percent.
There was a large increase in the use of digital mammography technology, which is more expensive than standard film technology ($115 versus $73 per mammogram). However, the newer technology has not been shown to be more effective in detecting breast cancer in women aged 65 and older, Yale School of Medicine researchers said.
They also discovered a significant increase in the use of other newer, more expensive technology for breast cancer screening and related procedures.
Overall, Medicare spending for breast cancer screening and related procedures rose from $666 million in 2001-02 to $962 million in 2008-09, according to a study in the July 1 issue of the Journal of the National Cancer Institute.
“Screening mammography is an important tool, but this rate of increase in cost is not sustainable,” study co-author Dr. Brigid Killelea, an assistant professor of surgery, said in a Yale news release.